convalescent plasma (Hospital Universitario Dr. Jose E. Gonzalez)

Convalescent plasma is a biological therapy derived from the blood of individuals who have recovered from a specific infection, such as COVID-19. This plasma contains neutralizing antibodies (immunoglobulins) generated by the donor's immune system that can target and neutralize the causative pathogen, in this case, the SARS-CoV-2 virus. The Hospital Universitario Dr. Jose E. Gonzalez initiated a Phase 2 clinical trial to evaluate the efficacy and safety of this therapy in patients with SARS-CoV-2 pneumonia, comparing it to the best available therapy to determine its impact on mortality and clinical recovery. The treatment involves the intravenous administration of fractionated plasma aliquots to provide passive immunity to infected subjects.

Other names

PlasmaConvalescent plasma from patients cured of COVID-19SARS-CoV-2 convalescent plasmaSARS-CoV2 convalescent plasmaSARS-CoV 2 convalescent plasma